Transaction DateRecipientSharesTypePriceValue
11th February 2021Oliver P Peoples866Payment by withholding$22.77$19,718.82
11th February 2021Kristi Snell693Payment by withholding$22.77$15,779.61
11th February 2021Lynne H Brum693Payment by withholding$22.77$15,779.61
11th February 2021Charles B Haaser693Payment by withholding$22.77$15,779.61
2nd February 2021Jack W Schuler54,132Other acquisition or disposition$9.87$534,282.84
1st February 2021Jack W Schuler100,000Other acquisition or disposition$11.40$1,140,000.00
29th January 2021Jack W Schuler30,868Open or private purchase$10.18$314,236.24
7th December 2020Jack W Schuler23,440Exercise of derivative$6.83$160,095.20
7th December 2020Jack W Schuler35,157Exercise of derivative$6.83$240,122.31
30th October 2020Jack W Schuler753,735Conversion of derivative$14.40$10,853,784.00
Yield10 Bioscience
Yield10 Bioscience logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Yield10 Bioscience, Inc. focuses on the development of technologies to produce step-change improvements in crop yield. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992.


Ticker: YTEN
Sector: Process Industries
Industry: Chemicals: Agricultural
SEC Central Index Key (CIK): 1121702
Employees: 25
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals